FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Rosemary Hannon

Research Profile

Concepts & Ideas

Physiology

Chemicals & Drugs

Disorders

Anatomy

Procedures

Double-Blind Method

Co-author Network

Publications

TOP 3
Rosemary A Hannon; Renee B Iacona; Martin Rimmer; José Baselga; Glen Clack; Richard D Finkelman; Fatma Gossiel; Richard Eastell
Effects of Src kinase inhibition by saracatinib (AZD0530) on bone turnover in advanced malignancy in a Phase I study.
Richard Eastell; Rosemary A Hannon; Jesus Rodriguez-Moreno; Dietrich Wenderoth; Andrzej Sawicki
Effect of stopping risedronate after long-term treatment on bone turnover.
Rosemary A Hannon; Glen Clack; Martin Rimmer; Alan Swaisland; J Andrew Lockton; Richard D Finkelman; Ana Munoz
Effects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men: a randomized, double-blind, placebo-controlled, multiple-ascending-dose phase I trial.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Rosemary Hannon (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Rosemary A Hannon; Renee B Iacona; Martin Rimmer; José Baselga; Glen Clack; Richard D Finkelman; Fatma Gossiel; Richard Eastell
Effects of Src kinase inhibition by saracatinib (AZD0530) on bone turnover in advanced malignancy in a Phase I study.
Bone 2012;50(4):885-92.
2011: Richard Eastell; Rosemary A Hannon; Jesus Rodriguez-Moreno; Dietrich Wenderoth; Andrzej Sawicki
Effect of stopping risedronate after long-term treatment on bone turnover.
The Journal of clinical endocrinology and metabolism 2011;96(11):3367-73.
2010: Rosemary A Hannon; Glen Clack; Martin Rimmer; Alan Swaisland; J Andrew Lockton; Richard D Finkelman; Ana Munoz
Effects of the Src kinase inhibitor saracatinib (AZD0530) on bone turnover in healthy men: a randomized, double-blind, placebo-controlled, multiple-ascending-dose phase I trial.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2010;25(3):463-71.
2008: James E Lester; David Dodwell; Om-Prakesh Purohit; Sandra A Gutcher; Susan P Ellis; Ruth Thorpe; Janet M Horsman; Janet E Brown; Rosemary A Hannon; Robert E Coleman
Prevention of anastrozole-induced bone loss with monthly oral ibandronate during adjuvant aromatase inhibitor therapy for breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(19):6336-42.
2008: Ana Munoz; Rosemary A Hannon
Biomarkers of bone health and osteoporosis risk.
The Proceedings of the Nutrition Society 2008;67(2):157-62.
2008: Ana Munoz; Judith E Adams; Robert E Coleman; Anthony Howell; Rosemary A Hannon; Jack Cuzick; John R Mackey; Matthias W Beckmann; Glen Clack
Effect of anastrozole on bone mineral density: 5-year results from the anastrozole, tamoxifen, alone or in combination trial 18233230.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(7):1051-7.
2008: Judith Finigan; Diana M Greenfield; Aubrey Blumsohn; Rosemary A Hannon; Nicola F Peel; Guirong Jiang; Ana Munoz
Risk factors for vertebral and nonvertebral fracture over 10 years: a population-based study in women.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2008;23(1):75-85.
2007: Eugene V McCloskey; Rosemary A Hannon; Geza Lakner; William D Fraser; Glen Clack; Anna Miyamoto; Richard D Finkelman; Ana Munoz
Effects of third generation aromatase inhibitors on bone health and other safety parameters: results of an open, randomised, multi-centre study of letrozole, exemestane and anastrozole in healthy postmenopausal women.
European journal of cancer (Oxford, England : 1990) 2007;43(17):2523-31.
2006: Ana Munoz; Rosemary A Hannon; Jack Cuzick; Mitch Dowsett; Glen Clack; Judith E Adams
Effect of an aromatase inhibitor on bmd and bone turnover markers: 2-year results of the Anastrozole, Tamoxifen, Alone or in Combination (ATAC) trial (18233230).
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2006;21(8):1215-23.
2004: Rosemary A Hannon; Jackie A Clowes; Alison C Eagleton; Amna Al Hadari; Ana Munoz; Aubrey Blumsohn
Clinical performance of immunoreactive tartrate-resistant acid phosphatase isoform 5b as a marker of bone resorption.
Bone 2004;34(1):187-94.
2003: Aubrey Blumsohn; Kim E Naylor; Wolfram Timm; Alison C Eagleton; Rosemary A Hannon; Ana Munoz
Absence of marked seasonal change in bone turnover: a longitudinal and multicenter cross-sectional study.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2003;18(7):1274-81.
2003: Ana Munoz; Ian P Barton; Rosemary A Hannon; AA Chines; P Garnero; P D Delmas
Relationship of early changes in bone resorption to the reduction in fracture risk with risedronate.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2003;18(6):1051-6.
2003: Rosemary A Hannon; Ana Munoz
Biochemical markers of bone turnover and fracture prediction.
The journal of the British Menopause Society 2003;9(1):10-5.
2002: C A Pereda; Rosemary A Hannon; Kim E Naylor; Ana Munoz
The impact of subcutaneous oestradiol implants on biochemical markers of bone turnover and bone mineral density in postmenopausal women.
BJOG : an international journal of obstetrics and gynaecology 2002;109(7):812-20.
2002: Jackie A Clowes; Rosemary A Hannon; T S Yap; Nicholas Hoyle; Aubrey Blumsohn; Ana Munoz
Effect of feeding on bone turnover markers and its impact on biological variability of measurements.
Bone 2002;30(6):886-90.
2000: A Rogers; Rosemary A Hannon; Ana Munoz
Biochemical markers as predictors of rates of bone loss after menopause.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 2000;15(7):1398-404.
1999: A Braga de Castro Machado; Rosemary A Hannon; Ana Munoz
Monitoring alendronate therapy for osteoporosis.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1999;14(4):602-8.
1998: Rosemary A Hannon; Aubrey Blumsohn; Kim E Naylor; Ana Munoz
Response of biochemical markers of bone turnover to hormone replacement therapy: impact of biological variability.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 1998;13(7):1124-33.
1996: N F Peel; Alexandra Smith; Rosemary A Hannon; Ana Munoz
Rate of bone loss from lumbar spine in women with distal forearm fracture.
BMJ (Clinical research ed.) 1996;312(7044):1457.
1995: N F Peel; N A Barrington; Aubrey Blumsohn; A Colwell; Rosemary A Hannon; Ana Munoz
Bone mineral density and bone turnover in spinal osteoarthrosis.
Annals of the rheumatic diseases 1995;54(11):867-71.
1995: Aubrey Blumsohn; Rosemary A Hannon; Ana Munoz
Apparent instability of osteocalcin in serum as measured with different commercially available immunoassays.
Clinical chemistry 1995;41(2):318-9.
1994: Aubrey Blumsohn; K Herrington; Rosemary A Hannon; P Shao; David R Eyre; Ana Munoz
The effect of calcium supplementation on the circadian rhythm of bone resorption.
The Journal of clinical endocrinology and metabolism 1994;79(3):730-5.
1994: Aubrey Blumsohn; Rosemary A Hannon; R Wrate; J Barton; A W al-Dehaimi; A Colwell; Ana Munoz
Biochemical markers of bone turnover in girls during puberty.
Clinical endocrinology 1994;40(5):663-70.
1994: R Graham G Russell; A Colwell; Rosemary A Hannon; Aubrey Blumsohn; A W al-Dehaimi; A M Assiri; N F Peel; Ana Munoz
Biochemical measurements in Paget's disease of bone.
Seminars in arthritis and rheumatism 1994;23(4):240-1.
1993: Ana Munoz; N F Peel; Rosemary A Hannon; Aubrey Blumsohn; A Price; A Colwell; R Graham G Russell
The effect of age on bone collagen turnover as assessed by pyridinium crosslinks and procollagen I C-terminal peptide.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 1993;3 Suppl 1():100-1.